Synthesis, DNA-binding and antiproliferative properties of diarylquinolizinium derivatives

Org Biomol Chem. 2021 Jan 28;19(4):878-890. doi: 10.1039/d0ob02298e. Epub 2021 Jan 7.

Abstract

A series of ten 2,7- and 2,8-diarylquinolizinium derivatives was synthesized and their DNA-binding and cytotoxic properties were investigated. Except for one nitro-substituted derivative all tested diarylquinolizinium ions bind to DNA with sufficient affinity (2 × 104 M-1-2 × 105 M-1). It was shown with photometric, fluorimetric and polarimetric titrations as well as with flow-LD analysis that the ligands bind mainly by intercalation to duplex DNA, however, depending on the ligand-DNA ratio, groove binding and backbone association were also observed with some derivatives. The biological activity was further investigated with tests of cytotoxicity and antiproliferative properties towards non-tumor cells and selected cancer cells, along with cell cycle analysis and an annexin-V assay. Notably, substrates that carry donor-functionalities in the 4-position of the phenyl substituents revealed a strong, and in some cases selective, antiproliferative activity as quantified by the growth inhibition, GI50, at very low micromolar and even submicromolar level both in leukemia and solid tumors.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Antineoplastic Agents / chemical synthesis*
  • Antineoplastic Agents / chemistry
  • Antineoplastic Agents / metabolism
  • Antineoplastic Agents / pharmacology*
  • Cell Line, Tumor
  • Cell Proliferation / drug effects
  • Chemistry Techniques, Synthetic
  • DNA / chemistry
  • DNA / metabolism*
  • Drug Design*
  • Humans
  • Ligands
  • Models, Molecular
  • Nucleic Acid Conformation
  • Quinolizines / chemical synthesis*
  • Quinolizines / chemistry
  • Quinolizines / metabolism
  • Quinolizines / pharmacology*

Substances

  • Antineoplastic Agents
  • Ligands
  • Quinolizines
  • DNA